← Leaderboards
Stuart Berger
Lurie Children'S Hospital Of Chicago
$585,228
Attributed
$1,306,572
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $898.2K · FY2023–24$1M$750K$500K$250K$0
'23
'24
Funding mix
By agency
NIH$1,306,572 · 1
By mechanism
UH3$1,306,572 · 1
Top collaborators
- Joshua M Hare2 shared
- Sunjay Kaushal1 shared
Most similar at Lurie Children'S Hospital Of Chicago
Same institution · by research overlap
- Sunjay Kaushal$9,064,158
- Karen K Mestan$3,490,544
- Kiona Allen$518,160
Others in their field
Other Rising Stars on “Design”
- Richard Smith · Medical Device Innovation Consortium$41,401,350
- Jeffrey Leintz · National Opinion Research Center$38,969,238
- Rhea Coler · Seattle Children'S Hospital$35,184,139
- Julia Louise Moore Vogel · Scripps Research Institute, The$32,252,685
- Christina Millin · Rho Federal Systems Division, Inc.$31,828,916
- Sabrina Paganoni · Massachusetts General Hospital$30,895,527
Research focus
DesignDiagnosisBackAllogenicArrhythmiaCardiacCardiac Magnetic Resonance ImagingCardiac MyocytesBasic ScienceAnastomosis - ActionBiological MarkersChildChildhoodCirculationClinical ResearchClinical Research SiteClinical TrialsComplexComputer ModelsCardiopulmonary BypassCaringData Coordinating CenterCell SecretionDown-Regulation
Grant awards (2)
1/2 Allogeneic Human Mesenchymal Stem Cell (MSC) Injection in Patients with Hypoplastic Left Heart Syndrome: A Phase IIb Clinical Trial$408,351
UH3 · FY2024 · HL · contact PI
1/2 Allogeneic Human Mesenchymal Stem Cell (MSC) Injection in Patients with Hypoplastic Left Heart Syndrome: A Phase IIb Clinical Trial$898,221
UH3 · FY2023 · HL · contact PI